Physician profile
Rajeev P Misra
NPI 1477752517
$183,125.29
in general payments reported to CMS, 2019-2025
10 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $895 · 2021: $33K · 2022: $42K · 2023: $28K · 2024: $33K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $4,321 · Travel and Lodging: $2,769 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $68,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $4,321.16 |
| Travel and Lodging | $2,768.79 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $180,909.93 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medical Device Business Services, INC. | $1,128.71 | 2022 | |
| Ethicon US, LLC | $423.06 | 2020-2022 | |
| Conmed Corporation | $173.17 | 2024 | Airseal |
| W. L. Gore & Associates, INC. | $150.41 | 2023 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Medtronic, INC. | $124.05 | 2025 | Signia, Progrip |
| Davol INC. | $119.43 | 2023-2024 | Phasix Mesh, Bard 3dmax Mesh |
| Smith+Nephew, INC. | $52.00 | 2019-2025 | Renasys Go V2 Home |
| Organogenesis INC. | $28.15 | 2024 | |
| Solventum Corporation | $16.38 | 2025 | Activ.A.C., V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Misra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.